Patent · US Active

Magnesium-substituted hydroxyapatites

US7704529B2 · kind B2 · utility

5Cited by

3References

9Claims

0Family size

Inventors

Richard E. Riman · Piscataway, US
Wojciech Suchanek · Solon, US
Pavel Shuk · Copley, US
Kevor S. TenHuisen · Clinton, US
Chun-Wei Chen · East Brunswick Township, US

Key dates

Filing date	Mar 25, 2005
Grant date	Apr 27, 2010
Priority date	—
Expiry date	Jan 11, 2027

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10T428/2982
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

A stable, phase-pure magnesium-substituted crystalline hydroxyapatite containing from about 2.0 to about 29 wt % magnesium, wherein at least 75 wt % of the magnesium content is substituted for calcium ions in the hydroxyapatite lattice structure.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.